Neutrophil extracellular traps in sterile inflammation: the story after dying?

References

• Tauber A. I.. Metchnikoff and the phagocytosis theory. Nat. Rev. Mol. Cell Biol. 2003; 4:897–901.
   PubMed Web of Science ®Google Scholar
• Brinkmann V., Reichard U., Goosmann C C., . Neutrophil extracellular traps kill bacteria. Science. 2004; 303:1532–1535.
   PubMed Web of Science ®Google Scholar
• Menegazzi R., Decleva E., Dri P.. Killing by neutrophil extracellular traps: fact or folklore?. Blood. 2012; 119:1214–1216.
   PubMed Web of Science ®Google Scholar
• Remijsen Q., Kuijpers T. W., Wirawan E., . Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ. 2011; 18:581–588.
   PubMed Web of Science ®Google Scholar
• Rada B., Leto T. L.. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib. Microbiol. 2008; 15:164–187.
   PubMedGoogle Scholar
• Hahn S., Gupta A. K., Troeger C., . Disturbances in placental immunology: ready for therapeutic interventions? Springer. Semin Immunopathol. 2006; 27:477–493.
   PubMed Web of Science ®Google Scholar
• Metzler K. D., Fuchs T. A., Nauseef W. M., . Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innateimmunity. Blood. 2011; 117:953–959.
   PubMed Web of Science ®Google Scholar
• Kessenbrock K., Krumbholz M., Schönermarck U., . Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 2009; 15:623–625.
   PubMed Web of Science ®Google Scholar
• Hakkim A., Fürnrohr B. G., Amann K., . Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. USA. 2010; 107:9813–9818.
   PubMed Web of Science ®Google Scholar
• Mantovani A., Cassatella M. A., Costantini C., . Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011; 11:519–531.
   PubMed Web of Science ®Google Scholar
• Tadema H., Abdulahad W. H., Stegeman C. A., . Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis. PLoS One. 2011; 6:e24–315.
   Google Scholar
• Lande R., Ganguly D., Facchinetti V., . Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA–peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 2011; 3:73ra19.
   PubMed Web of Science ®Google Scholar
• Tillack K., Breiden P., Martin R., . T lymphocyte priming neutrophil extracellular traps links innate and adaptive immuneresponses. J. Immunol. 2012; 188:3150–3159.
   PubMed Web of Science ®Google Scholar
• Dwivedi N., Upadhyay J., Neeli I., . Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum. 2012; 64:982–992.
   PubMedGoogle Scholar
• Kessenbrock K., Krumbholz M., Schönermarck U., . Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 2009; 15:623–625.
   PubMed Web of Science ®Google Scholar
• Garcia-Romo G. S., Caielli S., Vega B., . Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 2011; 3:73ra20.
   PubMed Web of Science ®Google Scholar
• Mitroulis I., Kambas K., Chrysanthopoulou A., . Neutrophil extracellular trap formation is associated with IL-1β and autophagy-related signaling in gout. PLoS One. 2011; 6:e29318.
   PubMed Web of Science ®Google Scholar
• Baker V. S., Imade G. E., Molta N. B., . Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age. Malar. J. 2008; 7:41.
   PubMed Web of Science ®Google Scholar
• Papayannopoulos V., Staab D., Zychlinsky A.. Neutrophilelastaseenhancessputumsolubilization in cystic fibrosis patients receiving DNase therapy. PLoS One. 2011; 6:e28526.
   PubMed Web of Science ®Google Scholar
• Csernok E., Lamprecht P., Gross W. L.. Clinical and immunological features of drug-induced and infection-inducedproteinase3-antineutrophilcytoplasmicantibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr. Opin. Rheumatol. 2010; 22:43–48.
   PubMed Web of Science ®Google Scholar
• Döring Y., Manthey H., Drechsler M., . Auto-antigenicprotein-DNAcomplexesstimulateplasmacytoiddendriticcells to promote atherosclerosis. Circulation. 2012; 125:1673–1683.
   Web of Science ®Google Scholar
• Yan J., Meng X., Wancket L. M., . Glutathione reductase facilitates host defense by sustaining phagocytic oxidative burst and promoting the development of neutrophil extracellular traps. J. Immunol. 2012; 188:2316–2327.
   Google Scholar
• Munoz L. E., Janko C., Chaurio R. A., . IgG opsonized nuclear remnants from dead cells cause systemic inflammation in SLE. Autoimmunity. 2010; 43:232–235.
   PubMed Web of Science ®Google Scholar
• Munoz L. E., Janko C., Grossmayer G. E., . Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum. 2009; 60:1733–1742.
   PubMed Web of Science ®Google Scholar
• Leadbetter E. A., Rifkin I. R., Hohlbaum A. M., . Chromatin-IgG complexes activate B cells bydualengagement of IgM and Toll-likereceptors. Nature. 2002; 416:603–607.
   PubMed Web of Science ®Google Scholar
• Häcker H., Mischak H., Miethke T., . CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 1998; 17:6230–6240.
   PubMed Web of Science ®Google Scholar
• Zeng D., Lee M. K., Tung J., . Cuttingedge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 2000; 164:5000–5004.
   PubMed Web of Science ®Google Scholar
• Bickerstaff M. C., Botto M., Hutchinson W. L., . Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med. 1999; 5:694–697.
   PubMed Web of Science ®Google Scholar
• Leffler J., Martin M., Gullstrand B., . Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J. Immunol. 2012; 188:3522–3531.
   PubMed Web of Science ®Google Scholar
• Fenton K., Fismen S., Hedberg A., . Anti-dsDNA antibodies promote initiation, and acquired loss of renal DNase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One. 2009; 4:e8474.
   Google Scholar
• Fuchs T. A., Abed U., Goosmann C., . Novel cell death program leads to neutrophil extracellular traps. J. Cell. Biol. 2007; 176:231–241.
   PubMed Web of Science ®Google Scholar
• Doss M., White M. R., Tecle T., . Human defensins and LL-37 in mucosal immunity. J. Leukoc. Biol. 2010; 87:79–92.
   PubMed Web of Science ®Google Scholar
• Denny M. F., Yalavarthi S., Zhao W., . A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol. 2010; 184:3284–3297.
   PubMed Web of Science ®Google Scholar
• Lamprecht P., Holle J., Gross W. L.. Update on clinical, pathophysiological and therapeutic aspects in ANCA-associated vasculitides. Curr. Drug Discov. Technol. 2009; 6:241–251.
   Google Scholar
• Phillipson M., Kubes P.. The neutrophil in vascular inflammation. Nat Med. 2011; 17:1381–1390.
   PubMed Web of Science ®Google Scholar
• Schorn C., Janko C., Munoz L., . Sodium and potassium urate crystals differ in their inflammatory potential. Autoimmunity. 2009; 42:314–316.
   PubMed Web of Science ®Google Scholar
• Schorn C., Frey B., Lauber K., . Sodium overload and water influx activate the NALP3 inflammasome. J. Biol. Chem. 2011; 286:35–41.
   PubMed Web of Science ®Google Scholar
• Martínez Valle F., Balada E., Ordi-Ros J., . DNase 1 and systemic lupus erythematosus. Autoimmun. Rev. 2008; 7:359–363.
   Google Scholar
• Gaubitz M., Seidel M., Kummer S., . Prospectiverandomizedtrial of twodifferentimmunoadsorbers in severesystemiclupuserythematosus. J. Autoimmun. 1998; 11:495–501.
   PubMed Web of Science ®Google Scholar
• Urbonaviciute V., Voll R. E.. High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus. J. Intern. Med. 2011; 270:309–318.
   Web of Science ®Google Scholar